IP Library Granted Patent US 7,795,038
Granted Patent B2
US 7,795,038 · App. 10/410,671 · Granted Sep 14, 2010

High-density lipoprotein assay device and method

Assignee: Cholestech Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,795,038
App. No.
10/410,671
Granted
Sep 14, 2010
Kind
B2
Abstract

An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design prevents interference by reagents used for such removal with the HDL quantification reaction or with other assays carried out on the same sample. If desired, removal of non-HDL lipoproteins and assay of HDL cholesterol can be carried out without interruption of the assay.

Claims (40)

1. An assay device for performing a non-HDL assay in conjunction with measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:

(a) a plurality of porous elements through which said blood fluid sample can flow in sequence by capillary action and/or gravity, said plurality comprising:

(i) a sample distribution matrix;

(ii) an HDL test pad, downstream of said matrix, in which HDL concentration can be assayed;

(iii) upstream of said HDL test pad, a reagent element containing an immobilized reagent, not soluble in the fluid sample, which is effective to selectively bind and remove non-HDL lipoproteins from the fluid sample; and

(iv) a non-HDL test pad, downstream of said sample distribution matrix, in which a non-HDL assay may be performed, wherein a sample flow path to the non-HDL test pad does not contain said reagent element; and

(b) mounting means effective to adjust the device between (a) a sample-distribution position, wherein the HDL test pad and the reagent element are not in fluid communication with the sample distribution matrix and are not in fluid communication with any element that removes cellular components, and further wherein the non-HDL test pad is not in fluid communication with the sample distribution matrix; and (b) a test position, wherein said HDL test pad, reagent element, and distribution matrix are in fluid communication with each other; while said non-HDL test pad is not in fluid communication with the reagent element.

2. The device of claim 1 , wherein the reagent element is a porous reagent pad located downstream of the distribution matrix.

3. The device of claim 2 , wherein the reagent pad is attached to the HDL test pad.

4. The device of claim 1 , further comprising a reaction bar to which said HDL test pad is attached.

5. The device of claim 4 , wherein said mounting means is effective to adjust the relative positions of the reaction bar between said sample-distribution position and said test position.

6. The device of claim 1 , wherein said mounting means is further effective to

(c) transfer the device from said test position to a position in which said HDL test pad is not in fluid communication with said sample distribution matrix.

7. The device of claim 1 , wherein said HDL test pad comprises a biosensor.

8. The device of claim 7 , wherein said biosensor is effective to electrochemically measure production of oxygen or hydrogen peroxide which is dependent on HDL-associated cholesterol concentration within said HDL test pad.

9. The device of claim 1 , wherein said reagent element comprises a porous polymeric membrane.

10. The device of claim 9 , wherein said polymeric membrane contains cationic surface groups.

11. The device of claim 1 , wherein said reagent element comprises multiple stacked membranes, at least one of which contains an immobilized reagent effective to bind non-HDL lipoproteins.

12. The device of claim 1 , wherein each of said HDL test pad and said reagent element is a porous polymeric membrane.

13. The device of claim 3 , wherein the HDL test pad and reagent pad are laminated together.

14. An assay device for performing a non-HDL assay in conjunction with measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:

(a) a sample distribution matrix for distributing the blood fluid sample;

(b) a reagent pad containing an immobilized reagent effective to selectively bind and remove non-HDL lipoproteins from the fluid sample;

(c) an HDL test pad in which HDL concentration can be assayed, downstream of said reagent pad; and

(d) a non-HDL test pad in which a non-HDL assay may be performed, wherein a sample flow path to the non-HDL test pad does not contain said reagent pad;

wherein the HDL test pad and the reagent pad can be positioned so that they are not in fluid communication with the sample distribution matrix and are not in fluid communication with any element that removes cellular components, and further wherein the non-HDL test pad is not in fluid communication with the sample distribution matrix; and

wherein said HDL test pad, reagent pad, and distribution matrix are brought into fluid communication with each other; while said non-HDL test pad is not in fluid communication with the reagent pad.

15. The device of claim 14 , wherein said immobilized reagent comprises a sulfonated polysaccharide, and said reagent pad comprises a porous polymeric membrane having cationic surface groups.

16. The device of claim 1 , wherein the HDL test pad includes a cholesterol-assaying enzyme reagent.

17. The device of claim 16 , wherein the cholesterol-assaying enzyme reagent comprises cholesterol esterase and cholesterol oxidase.

18. The device of claim 1 , wherein the immobilized reagent is dextran sulfate immobilized by electrostatic forces to the reagent element having positively charged surface groups.

19. An assay device for performing a non-HDL assay in conjunction with measuring serum cholesterol associated with high-density lipoproteins (HDL) in a blood fluid sample also containing low density lipoproteins (LDL) or very low density lipoproteins (VLDL), the device comprising:

(a) a plurality of porous elements through which said blood fluid sample can flow in sequence by capillary action and/or gravity, said plurality comprising:

(i) a sample distribution matrix;

(ii) an HDL test pad, downstream of said matrix, in which HDL concentration can be assayed;

(iii) upstream of said HDL test pad, a reagent pad containing an immobilized reagent, wherein said immobilized reagent which is not soluble in the fluid sample, selectively binds and removes non-HDL lipoproteins from the fluid sample, and remains entrapped within said reagent pad; and

(iv) a non-HDL test pad, downstream of said sample distribution matrix, in which a non-HDL assay may be performed, wherein a sample flow path to the non-HDL test pad does not contain said reagent element; and

(b) mounting means effective to adjust the device between (a) a sample-distribution position, wherein the HDL test pad and the reagent element are not in fluid communication with the sample distribution matrix and are not in fluid communication with any element that removes cellular components, and further wherein the non-HDL test pad is not in fluid communication with the sample distribution matrix; and (b) a test position, wherein said HDL test pad, reagent element, and distribution matrix are in fluid communication with each other; while said non-HDL test pad is not in fluid communication with the reagent element.

20. The device of claim 19 , wherein said non-HDL assay is a total cholesterol assay.

21. The device of claim 19 , wherein said non-HDL assay is a triglyceride assay.

Assignments (9)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY RECORDED AT REEL 036994, FRAME 0192 AND REEL 037115, FRAME 0498 Recorded Oct 5, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS COLLATERAL AGENT
To: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
Reel/Frame 044213/0258 →
ASSIGNMENT OF IP SECURITY AGREEMENT, PREVIOUSLY RECORDED AT REEL 036994, FRAME 0192 Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING ADMINISTRATIVE AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 037115/0498 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 29, 2015
From: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 036994/0192 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287 Recorded Jun 23, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL, INC.; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.; AMEDITECH INC.; APPLIED BIOTECH, INC.; BINAX, INC.; BIOSITE INCORPORATED; CHOLESTECH CORPORATION; GENECARE MEDICAL GENETICS CENTER, INC.; HEMOSENSE, INC.; INSTANT TECHNOLOGIES, INC.; INVERNESS MEDICAL - BIOSTAR INC.; ISCHEMIA TECHNOLOGIES, INC.; MATRITECH, INC.; MATRIA HEALTHCARE, INC.; ZYCARE, INC.
Reel/Frame 036011/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2012
From: CHOLESTECH CORPORATION
To: ALERE SAN DIEGO, INC
Reel/Frame 028349/0077 →
SECURITY AGREEMENT Recorded Jul 7, 2011
From: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL INCORPORATED; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.; AMEDITECH INC.; APPLIED BIOTECH, INC.; BINAX, INC.; BIOSITE INCORPORATED; CHOLESTECH CORPORATION; GENECARE MEDICAL GENETICS CENTER, INC.; HEMOSENSE, INC.; INSTANT TECHNOLOGIES, INC.; INVERNESS MEDICAL - BIOSTAR INC.; ISCHEMIA TECHNOLOGIES, INC.; MATRITECH, INC.; ZYCARE INC.; MARTIA HEALTHCARE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 026557/0287 →
SECURITY AGREEMENT Recorded Oct 18, 2007
From: CHOLESTECH CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 019974/0530 →
SECURITY AGREEMENT Recorded Oct 17, 2007
From: CHOLESTECH CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 019974/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2003
From: JONES, RONALD M.; WORTHY, THOMAS E.; SHINDELMAN, JEFFREY; BELLET, NEAL F.; NUGENT, ANTHONY J.
To: CHOLESTECH CORPORATION
Reel/Frame 014350/0786 →
Continuity (2)
Provisional Application 6037109300 · Apr 9, 2002
Related Publication 20030224471A1 · Dec 4, 2003